Relaxant effect of YM976, a novel phosphodiesterase 4 inhibitor, on bovine tracheal smooth muscle

European Journal of Pharmacology

Volumn 470, Issue 1-2, 2003, Pages 57-64

  Moriuchi, Hiroshi ^a   Nakahara, Tsutomu ^a   Maruko, Takeshi ^a   Sakamoto, Kenji ^a   Ishii, Kunio ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

cAMP; Phosphodiesterase type 4; Relaxation; Smooth muscle, Tracheal

Indexed keywords

4 (3 CHLOROPHENYL) 1,7 DIETHYLPYRIDO[2,3 D]PYRIMIDIN 2(1H) ONE; CYCLIC AMP; HISTAMINE; METHACHOLINE; ROLIPRAM; THEOPHYLLINE;

ANIMAL TISSUE; ARTICLE; CATTLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; TRACHEA;

EID: 0037684940     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01754-0     Document Type: Article

References (37)

1. Aoki M., Kobayashi M., Ishikawa J., Saita Y., Terai Y., Takayama K., Miyata K., Yamada T. A novel phoshodiesterase type 4 inhibitor, YM976 (4-(3-chlorophenyl)-1,7,-diethypyrido[2,3-d]pyrimidin-2(1H)-one), with little emetogenic activity. J. Pharmacol. Exp. Ther. 295:2000;255-260.
2. Aoki M., Fukunaga M., Sugimoto T., Hirano Y., Kobayashi M., Honda K., Yamada T. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor. J. Pharmacol. Exp. Ther. 298:2001;1142-1149.
3. Aoki M., Yamamoto S., Kobayashi M., Ohga K., Kanoh H., Miyata K., Honda K., Yamada T. Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs. J. Pharmacol. Exp. Ther. 297:2001;165-173.
4. Beavo J.A. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75:1995;725-748.
5. Bernareggi M.M., Belvisi M.G., Patel H., Barnes P.J., Giembycz M.A. Anti-spasmogenic activity of isoenzyme-selective phosphodiesterase inhibitors in guinea-pig trachealis. Br. J. Pharmacol. 128:1999;327-336.
6. 3 generation and functional responses by selective inhibitors of types 3 and 4 phosphodiesterase in airways smooth muscle. Br. J. Pharmacol. 124:1998;47-54.
7. Dent G., Giembycz M.A., Rabe K.F., Barnes P.J. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by "type IV-selective PDE inhibitors" Br. J. Pharmacol. 103:1991;1339-1346.
8. 2 agonists and antagonists. J. Pharmacol. Exp. Ther. 215:1980;434-442.
9. Fawcett L., Baxendale R., Stacey P., McGrouther C., Harrow I., Soderling S., Hetman J., Beavo J.A., Phillips S.C. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. Proc. Natl. Acad. Sci. U. S. A. 97:2000;3702-3707.
10. Fisher D.A., Smith J.F., Pillar J.S., St. Denis S.H., Cheng J.B. Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J. Biol. Chem. 273:1998;15559-15564.
11. Fisher D.A., Smith J.F., Pillar J.S., St. Denis S.H., Cheng J.B. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase. Biochem. Biophys. Res. Commun. 246:1998;570-577.
12. Fujii K., Kohrogi H., Iwagoe H., Hamamoto J., Hirata N., Goto E., Kawano O., Wada K., Yamagata S., Ando M. Novel phosphodiesterase 4 inhibitor T-440 reverses and prevents human bronchial contraction induced by allergen. J. Pharmacol. Exp. Ther. 284:1998;162-169.
13. Fujishige K., Kotera J., Michibata H., Yuasa K., Takebayashi S., Okumura K., Omori K. Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A). J. Biol. Chem. 274:1999;18438-18445.
14. Germain N., Bertin B., Legendre A., Martin B., Lagente V., Payne A., Boichot E. Selective phosphodiesterase inhibitors modulate the activity of alveolar macrophages from sensitized guinea-pigs. Eur. Respir. J. 12:1998;1334-1339.
15. Goncalves de Moraes V.L., Singer M., Vargaftig B.B., Chignard M. Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide-induced inflammation in mouse lung. Br. J. Pharmacol. 123:1998;631-636.
16. Giembycz M.A., Barnes P.J. Selective inhibition of a high affinity type IV cyclic AMP phosphodiesterase in bovine trachealis by AH 21-132. Relevance to the spasmolytic and anti-spasmogenic actions of AH 21-132 in the intact tissue. Biochem. Pharmacol. 42:1991;663-677.
17. Hall I.P., Hill S.J. Effects of isozyme selective phosphodiesterase inhibitors on bovine tracheal smooth muscle tone. Biochem. Pharmacol. 43:1992;15-17.
18. Hall I.P., Donaldson J., Hill S.J. Inhibition of histamine-stimulated inositol phospholipid hydrolysis by agents which increase cyclic AMP levels in bovine tracheal smooth muscle. Br. J. Pharmacol. 97:1989;603-613.
19. Hall I.P., Donaldson J., Hill S.J. Modulation of carbachol-induced inositol phosphate formation in bovine tracheal smooth muscle by cyclic AMP phosphodiesterase inhibitors. Biochem. Pharmacol. 39:1990;1357-1363.
20. Harris A.L., Connel M.J., Ferguson E.W., Wallace A.M., Gordon R.J., Pagani E.D., Silver P.J. Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig. J. Pharmacol. Exp. Ther. 251:1989;199-206.
21. Hayashi M., Matsushima K., Ohashi H., Tsunoda H., Murase S., Kawarada Y., Tanaka T. Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3′,5′-cyclic nucleotide phosphodiesterase. Biochem. Biophys. Res. Commun. 250:1998;751-756.
22. Heaslip R.J., Lombardo L.J., Golankiewicz J.M., Ilsemann B.A., Evans D.Y., Sickels B.D., Mudrick J.K., Bagli J., Weichman B.M. Phosphodiesterase-IV inhibition, respiratory muscle relaxation and bronchodilation by WAY-PDA-641. J. Pharmacol. Exp. Ther. 268:1994;888-896.
23. Hetman J.M., Soderling S.H., Glavas N.A., Beavo J.A. Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase. Proc. Natl. Acad. Sci. U. S. A. 97:2000;472-476.
24. Holbrook M., Gozzard N., James T., Higgs G., Hughes B. Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitor. Br. J. Pharmacol. 118:1996;1192-1200.
25. Katsuki S., Murad F. Regulation of adenosine cyclic 3′,5′-monophosphate and guanosine cyclic 3′,5′-monophosphate levels and contractility in bovine tracheal smooth muscle. Mol. Pharmacol. 13:1977;330-341.
26. Loughney K., Snyder P.B., Uher L., Rosman G.J., Ferguson K., Florio V.A. Isolation and characterization of PDE10A, a novel human 3′,5′-cyclic nucleotide phosphodiesterase. Gene. 234:1999;109-117.
27. Muller T., Engels P., Fozard J.R. Subtypes of the type 4 cAMP phosphodiesterase: structure, regulation and selective inhibition. Trends Pharmacol. Sci. 17:1996;294-298.
28. Peachell P.T., Undem B.J., Schleimer R.P., MacGlashan D.W. Jr., Lichtenstein L.M., Cieslinski L.B., Torphy T.J. Preliminary identification and role of phosphodiesterase isozymes in human. J. Immunol. 148:1992;2503-2510.
29. Raeburn D., Underwood S.L., Lewis S.A., Woodman V.R., Battram C.H., Tomkinson A., Sharma S., Jordan R., Souness J.E., Webber S.E., Karlsson J.-A. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Br. J. Pharmacol. 113:1994;1423-1431.
30. Shahid M., van Amsterdam R.G.M., de Boer J., Ten Berge R.E., Nicholson C.D., Zaagsma J. The presence of five cyclic nucleotide phosphodiesterase isoenzymes activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors. Br. J. Pharmacol. 104:1991;471-477.
31. Soderling S.H., Bayuga S.J., Beavo J.A. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7071-7076.
32. Souness J.E., Rao S. Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases. Cell Signal. 9:1997;227-236.
33. Torphy T.J., Burman M., Huang L.B.F., Tucker S.S. Inhibition of the low Km cyclic AMP phosphodiesterase in intact canine trachealis by SK&F 94836: mechanical and biochemical responses. J. Pharmacol. Exp. Ther. 246:1988;843-850.
34. Torphy T.J., Barnette M.S., Underwood D.C., Griswold D.E., Christensen S.B., Murdoch R.D., Nieman R.B., Compton C.H. Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic. Pulm. Pharmacol. Ther. 12:1999;131-135.
35. Underwood D.C., Osborn R.R., Novak L.B., Matthews J.K., Newsholme S.J., Undem B.J., Hand J.M., Torphy T.J. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. J. Pharmcaol. Exp. Ther. 266:1993;306-313.
36. Underwood D.C., Kotzer C.J., Bochnowicz S., Osborn R.R., Luttmann M.A., Hay D.W.P., Torphy T.J. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. J. Pharmcaol. Exp. Ther. 270:1994;250-259.
37. Weston M.C., Anderson N., Peachell P.T. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function. Br. J. Pharmacol. 121:1997;287-295.